Followers | 416 |
Posts | 34739 |
Boards Moderated | 1 |
Alias Born | 08/22/2004 |
Tuesday, July 20, 2021 10:32:34 AM
Recent IMNM News
- Immunome Appoints Phil Tsai as Chief Technical Officer • Business Wire • 06/27/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:08:29 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:05:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:01:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 12:56:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 12:48:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:42 PM
- Immunome Announces Completion of Purchase of Assets from Atreca • Business Wire • 05/20/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:11:18 PM
- Immunome Announces Promotion of Max Rosett to Chief Financial Officer • Business Wire • 05/17/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/14/2024 12:48:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:02:25 PM
- Immunome Reports First Quarter 2024 Financial Results and Provides Business Update • Business Wire • 05/14/2024 12:00:00 PM
- Immunome to Present at 2024 Bank of America Healthcare Conference • Business Wire • 05/08/2024 12:00:00 PM
- Immunome Appoints Kinney Horn as Chief Business Officer • Business Wire • 05/02/2024 12:00:00 PM
- Immunome Appoints Sandra M. Swain to Board of Directors • Business Wire • 04/25/2024 12:26:00 PM
- Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting • Business Wire • 04/05/2024 12:00:00 PM
- Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets • Business Wire • 03/28/2024 08:02:00 PM
- Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala • Business Wire • 03/26/2024 12:00:00 PM
- Immunome to Participate in the Leerink Partners Global Biopharma Conference • Business Wire • 03/07/2024 01:00:00 PM
- Immunome to Participate in the TD Cowen 44th Annual Healthcare Conference • Business Wire • 03/01/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:10:50 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:07:36 AM
- Immunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors • Business Wire • 02/20/2024 01:15:00 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM